Elsevier, Environmental Toxicology and Pharmacology, 2(35), p. 254-264
DOI: 10.1016/j.etap.2012.12.010
Full text: Download
The current work investigates the influence of novel dinuclear platinum(II) compounds of structure: Pt(2)(3-ethylpyridine)(4)(berenil)(2) (Pt10) and Pt(2)(3-butylpyridine)(4)(berenil)(2) (Pt11) on growth and viability of MDA-MB-231 and MCF-7 breast cancer cells as well as their putative mechanism of cytotoxicity. Evaluation of the cytotoxicity of Pt10 and Pt11 employing a MTT assay and inhibition of [(3)H]thymidine incorporation into DNA in both MDA-MB-231 and MCF-7 breast cancer cells demonstrated that these compounds were more potent antiproliferative agents than cisplatin. In our study the induction of apoptosis by Pt10 and Pt11 in human breast cancer cells was confirmed by several biochemical markers, such as: phosphatidylserine externalization, loss of mitochondrial membrane potential ΔΨ(m), caspase-3, -8, -9 activity, and DNA degradation. Pt10 and Pt11 induce apoptosis of breast cancer cells via mechanisms dependent on caspases activation and associated with mitochondrial membrane potential disruption.